1759-4774
Health Score
0 Fair
Metadata coverage
Your prioritized action plan
Ordered by how many DOIs each fix touches — start here, not with every error at once.
1
Add abstracts to 9 articles
Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.
High impact9 DOIs
2
Attach ORCID iDs across 9 articles
ORCID iDs strengthen author disambiguation and institutional reporting.
High impact9 DOIs
DOIs for this ISSN
| # | Title | Missing | Priority | Citations |
|---|---|---|---|---|
| 1 | Hodgkin lymphoma—absence of evidence not evidence of absence… (10.1038/nrclinonc.2011.149) | Abstract ORCID | 23.86 | 2 |
| 2 | Exon 11 KIT genotype improves outcome in imatinib treated GI… (10.1038/ncponc1310) | Abstract ORCID | 0.00 | 0 |
| 3 | A personal note—40 years after the signing of the Cancer Act (10.1038/nrclinonc.2011.168) | Abstract ORCID | 0.00 | 0 |
| 4 | Tivantinib shows promise in hepatocellular carcinoma (10.1038/nrclinonc.2012.110) | Abstract ORCID | 0.00 | 0 |
| 5 | For elderly, R-CHOP and maintain (10.1038/nrclinonc.2012.152) | Abstract ORCID | 0.00 | 0 |
| 6 | Benefit for low-dose, alternate-day aspirin use for CRC (10.1038/nrclinonc.2013.143) | Abstract ORCID | 0.00 | 0 |
| 7 | CTCs and benefit from radiotherapy (10.1038/s41571-018-0042-y) | Abstract ORCID | 0.00 | 0 |
| 8 | Tasadenoturev active in DIPG (10.1038/s41571-022-00666-6) | Abstract ORCID | 0.00 | 0 |
| 9 | A new standard of care for advanced-stage urothelial carcino… (10.1038/s41571-024-00884-0) | Abstract ORCID | 0.00 | 0 |